Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Ned Tijdschr Tandheelkd ; 131(7-08): 331-334, 2024 Jul.
Article in Dutch | MEDLINE | ID: mdl-38973663

ABSTRACT

A recent publication in the Nederlands Tijdschrift Voor Tandheelkunde (Dutch Journal of Dentistry) suggests botulinum toxin as a primary treatment for bruxism, especially for severe complaints of teeth grinding or jaw clenching. However, in the opinion of Lobbezoo et al., some outdated views on bruxism are used, and botulinum toxin is incorrectly classified as safe, according to them. In this Vision article, the authors describe the current insights into bruxism; they indicate how the presence of bruxism can be assessed in the clinic; when and how bruxism is treated; and finally, what the role of botulinum toxin is: an ultimum refugium. Therefore, regarding the use of botulinum toxin within the discipline of orofacial pain and dysfunction Lobbezoo et al. recommend: think twice!


Subject(s)
Botulinum Toxins , Bruxism , Humans , Bruxism/drug therapy , Botulinum Toxins/therapeutic use , Botulinum Toxins/administration & dosage , Neuromuscular Agents/therapeutic use , Neuromuscular Agents/administration & dosage , Botulinum Toxins, Type A/therapeutic use , Botulinum Toxins, Type A/administration & dosage
2.
Ned Tijdschr Tandheelkd ; 130(9): 359-363, 2023 Sep.
Article in Dutch | MEDLINE | ID: mdl-37667631

ABSTRACT

A young woman, known to have glycogen storage disease type 1B (GSD1B) presents with severe periodontitis. GDS1B causes decreased hepatic and renal glucose production and in many cases neutropenia and neutrophil dysfunction leading to recurrent infections. It was decided to treat the patient by extraction of the most affected teeth and retention of the remaining teeth through periodontal treatment, both with antibiotic prophylaxis. After a follow-up period of 1.5 years, during which there was no visible improvement, it was decided to do a full dental extraction and fabricate complete dentures. Due to subsequent bone resorption in both jaws, the dentures were not functional. After consulting the internist and the oral and maxillofacial surgeon, the decision was then made to place dental implants in both the upper and lower jaw for implant-supported prosthetics. After successful treatment and an osseointegration period, the prosthetics were placed. 1 year after placement, there is a stable implantological situation, without pockets or apparent bone loss. The start of SGLT2 medication may have played a significant role in this.


Subject(s)
Glycogen Storage Disease Type I , Medicine , Female , Humans , Glycogen Storage Disease Type I/complications , Antibiotic Prophylaxis , Dental Care
3.
Ned Tijdschr Tandheelkd ; 129(4): 175-183, 2022 Apr.
Article in Dutch | MEDLINE | ID: mdl-35420275

ABSTRACT

Treatment of odontogenic infections, such as drainage of submucosal abscesses, should be carried out by the dental practitioner. However, when an odontogenic infection deteriorates into a deep neck abscess, treatment should be carried out by the oral maxillofacial surgeon. Based on two cases, this article describes the clinical presentation, course, and necessary treatment of a deep neck abscess. It also points out that timely recognition of the disease is key in treatment. In any case of delay, there is a possibility for fast deterioration by complications, such as airway obstruction, development of descending necrotizing mediastinitis, or sepsis. Oral health practitioners play an important role in early identification of a deep neck abscess. This article proposes recommendations for dentists when to suspect a deep neck infection, which could be useful in quick and adequate referral to an OMF surgeon.


Subject(s)
Abscess , Mediastinitis , Abscess/complications , Abscess/diagnosis , Abscess/surgery , Dentists , Drainage/adverse effects , Drainage/methods , Humans , Mediastinitis/etiology , Mediastinitis/surgery , Neck/surgery , Professional Role
4.
Ned Tijdschr Tandheelkd ; 129(4): 185-192, 2022 04.
Article in Dutch | MEDLINE | ID: mdl-35420276

ABSTRACT

Inflammation begins as a response of the immune system to an external, harmful stimulus. This stimulus can be chemical, mechanical or bacterial in nature. The inflammatory response is necessary to create optimal conditions for healing. In case of pulpitis, a peri-apical granuloma, peri-coronitis or periodontitis, complaints arise as a result of an inflammatory reaction. With further progression, such as an infiltrate or a submucosal abscess, the bacteria will eventually invade the tissues and develop an infection. Given the high prevalence of dental diseases, oral health care providers are regularly confronted with the consequences of dentogenic inflammation and subsequent infections. Each specific stage of dentogenic inflammation presents symptoms that are important for making the correct diagnosis. This is important in applying the optimal dental, surgical or medical treatment.


Subject(s)
Inflammation , Periodontitis , Humans , Inflammation/diagnosis
5.
Ned Tijdschr Tandheelkd ; 127(5): 302-308, 2020 May.
Article in Dutch | MEDLINE | ID: mdl-32609101

ABSTRACT

In dental trauma, the first thought is often: 'Where is that tooth?' And, of course, it is certainly true that fast repositioning is beneficial for the prognosis of the tooth. Nevertheless, it is extremely important to focus on the condition of the patient before focussing on the treatment. A structured approach is mandatory for optimal diagnosis and treatment. This includes possible concomitant injuries such as neurotrauma. The principle of initial screening of the severity of the injury is called triage. There is a clear difference in the severity of injuries of patients with dental trauma presenting themselves in hospital or the dental practice. In hospital there are protocols for primary care; these principles can be applied in the dental practice as well.


Subject(s)
Triage , Humans , Prognosis
6.
J Clin Transl Res ; 6(6): 225-235, 2020 Dec 11.
Article in English | MEDLINE | ID: mdl-33564727

ABSTRACT

BACKGROUND/AIM/OBJECTIVE: Late side effects of radiotherapy (RT) in the treatment for head and neck (HN) malignancies involve an inadequate healing response of the distressed tissue due to RT-induced hypovascularity. The aim of this study was to develop a pilot model in which vascular alterations associated with the onset of late irradiation (IR) injury could be measured in rabbit oral mucosa and mandibular bone. MATERIALS AND METHODS: Eight male New Zealand white rabbits were divided over four treatment groups. Group I-III received four fractions of RT (5.6 Gy, 6.5 Gy, and 8 Gy, respectively) and Group IV received 1 fraction of 30 Gy. Oral microcirculatory measurements were performed at baseline (before RT) and once a week during 11 consecutive weeks after RT assessing perfusion parameters, that is, total vessel density (TVD), perfused vessel density (PVD), proportion of perfused vessels (PPV), and microvascular flow index (MFI). Post-mortem histopathology specimens were analyzed. RESULTS: Five weeks after RT, TVD, and PVD in all groups showed a decrease of >10% compared to baseline, a significant difference was observed for Groups I, II, and IV (P<0.05). At T11, no lasting effect of decreased vessel density was observed. PPV and MFI remained unaltered at all-time points. Group IV showed a marked difference in scattered telangiectasia such as microangiopathies, histological necrosis, and loss of vasculature. CONCLUSION: No significant lasting effect in mucosal microcirculation density due to IR damage was detected. Observed changes in microcirculation vasculature and histology may align preliminary tissue transition towards clinical pathology in a very early state associated with late IR injury in the oral compartment. RELEVANCE FOR PATIENTS: Enhancing knowledge on the onset of late vascular IR injury in the HN region could help the development, monitoring, and timing of therapies that act on prevention, discontinuation, or repair of radiation pathology.

7.
Allergy ; 71(4): 567-70, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26645423

ABSTRACT

The objective of the study was to compare nasal, pharyngeal, and sputum eosinophil peroxidase (EPX) levels with induced sputum eosinophil percentage in 10 adults with poorly controlled asthma and 10 normal controls. EPX was measured using an ELISA and normalized for grams of protein for nasal and pharynx specimens and for mL-gram of protein for sputum. Sputum EPX levels were statistically different between asthma and control subjects (P = 0.024). EPX levels measured in the nasal and pharyngeal swab samples derived from the same patients were also different between asthma and control subjects, each displaying a high degree of significance (P = 0.002). Spearman's correlation coefficients for nasal EPX and pharyngeal EPX levels compared to induced sputum eosinophil percentage were 0.81 (P = 0.0007) and 0.78 (P = 0.0017), respectively. Thus, there is a strong association in a given patient between both nasal and pharyngeal EPX levels and the eosinophil percentage of induced sputum.


Subject(s)
Asthma/diagnosis , Asthma/metabolism , Eosinophil Peroxidase/metabolism , Eosinophils/enzymology , Eosinophils/pathology , Nasal Mucosa/metabolism , Pharynx/metabolism , Sputum/enzymology , Adult , Asthma/drug therapy , Case-Control Studies , Disease Management , Female , Humans , Male , Middle Aged
8.
Cells Tissues Organs ; 190(1): 42-52, 2009.
Article in English | MEDLINE | ID: mdl-18784411

ABSTRACT

We examined the difference in fiber type composition and cross-sectional areas during postnatal development in male rabbit jaw muscles and compared these with changes in leg muscles. The myosin heavy chain (MyHC) content of the fibers was determined by immunohistochemistry. No fiber type difference was found between the jaw muscles in 20-week-old rabbits. However, the way this adult fiber type composition was reached differed between the muscles. The deep temporalis, medial pterygoid, and superficial masseter displayed an increase in alpha fibers during early and a decrease during late postnatal development. Other jaw muscles displayed an increase in alpha fibers during early development only. In contrast, alpha fibers were not found in the soleus, in which fiber type changes were completed at week 4. The gastrocnemius muscle did not change its fiber type composition. Initially, fibers in jaw-opening muscles had larger cross-sectional areas than in other muscles, but they increased less during development. Although there were no large differences in the fiber type composition of muscles in young adult rabbits, large differences were found in the jaw muscles, but not in the leg muscles, during development. In part, these developmental changes in fiber percentages within the jaw muscles can be explained by functional modifications in this muscle group. In the present study, the deep temporalis, medial pterygoid, and superficial masseter showed the most dramatic percent changes in fibers during postnatal development.


Subject(s)
Extremities/growth & development , Growth and Development , Jaw/metabolism , Muscle Fibers, Skeletal/metabolism , Muscles/metabolism , Aging , Animals , Animals, Newborn , Extremities/anatomy & histology , Jaw/anatomy & histology , Male , Muscle Fibers, Fast-Twitch/cytology , Muscle Fibers, Skeletal/cytology , Muscles/cytology , Rabbits
9.
Ann Diagn Pathol ; 7(2): 127-38, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12715340

ABSTRACT

Agranulomatous interstitial pneumonia is a form of diffuse lung disease in which granulomas are a component of the histologic findings. The differential diagnosis is quite broad, but most cases represent examples of either sarcoidosis, diffuse granulomatous infections, or hypersensitivity pneumonitis. "Hot tub lung" is a recently described form of granulomatous interstitial pneumonia that appears to have some features of diffuse infections and some features of hypersensitivity pneumonitis. The pathologist's approach to these conditions can be facilitated by giving careful attention to the anatomic distribution of the granulomas, the qualitative features of the granulomas, and the histologic changes in the lung tissue around and away from the granulomas. These features, along with the results of cultures and special stains for micro-organisms and clinical and radiologic correlation allow for a diagnosis in the vast majority of cases.


Subject(s)
Lung Diseases, Interstitial/etiology , Lung Diseases, Interstitial/pathology , Lung/pathology , Diagnosis, Differential , Granuloma/pathology , Granuloma/surgery , Humans , Lung/surgery , Lung Diseases, Interstitial/surgery
10.
Ann Diagn Pathol ; 5(5): 309-19, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11598860

ABSTRACT

The pathologist's approach to pulmonary hemorrhage is outlined. Most cases fall into those examples of pulmonary hemorrhage caused by localized sites of bleeding, and those examples that fall within the spectrum of diffuse alveolar hemorrhage. The histologic evaluation of pulmonary hemorrhage is outlined including assessment of fresh hemorrhage in alveolar spaces (including exclusion of traumatic hemorrhage related to the procedure) and the presence of hemosiderin and its various causes. The most common causes of diffuse alveolar hemorrhage and clues to their clinically pathologic diagnosis are discussed.


Subject(s)
Hemorrhage/pathology , Lung Diseases/pathology , Hemothorax/pathology , Humans
11.
Am J Respir Crit Care Med ; 164(2): 193-6, 2001 Jul 15.
Article in English | MEDLINE | ID: mdl-11463586

ABSTRACT

It is not known if a surgical lung biopsy is necessary in all patients for the diagnosis of idiopathic pulmonary fibrosis (IPF). We conducted a blinded, prospective study at eight referring centers. Initially, cases were evaluated by clinical history and examination, transbronchial biopsy, and high-resolution lung computed tomography scans. Pulmonologists at the referring centers then assessed their certainty of the diagnosis of IPF and provided an overall diagnosis, before surgical lung biopsy. The lung biopsies were reviewed by a pathology core and 54 of 91 patients received a pathologic diagnosis of IPF. The positive predictive value of a confident (certain) clinical diagnosis of IPF by the referring centers was 80%. The positive predictive value of a confident clinical diagnosis was higher, when the cases were reviewed by a core of pulmonologists (87%) or radiologists (96%). Lung biopsy was most important for diagnosis in those patients with an uncertain diagnosis and those thought unlikely to have IPF. These studies suggest that clinical and radiologic data that result in a confident diagnosis of IPF by an experienced pulmonologist or radiologist are sufficient to obviate the need for a lung biopsy. Lung biopsy is most helpful when clinical and radiologic data result in an uncertain diagnosis or when patients are thought not to have IPF.


Subject(s)
Pulmonary Fibrosis/pathology , Biopsy , Humans , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity
12.
Am J Clin Pathol ; 115(5): 755-62, 2001 May.
Article in English | MEDLINE | ID: mdl-11345841

ABSTRACT

The clinicopathologic spectrum of infections due to nontuberculous mycobacteria (NTM) includes cavitary disease, opportunistic infection, and nodular disease associated with bronchiectasis. We report a less well-described manifestation of NTM infection: 10 immunocompetent patients without preexisting bronchiectasis had radiographic evidence of diffuse infiltrative lung disease. The most common symptoms were dyspnea, cough, hypoxia, and fever. All 10 patients had used a hot tub. Histologic examination revealed exuberant nonnecrotizing, frequently bronchiolocentric, granulomatous inflammation in all cases. In 1 case, necrotizing granulomas were also noted. The inflammation often was associated with patchy chronic interstitial pneumonia and organization. Cultures revealed NTM in all cases (Mycobacterium avium complex in all but 1 case), but staining for acid-fast bacilli was positive in only 1 case. Four patients received corticosteroids alone for presumed hypersensitivity pneumonia, 4 were treated with antimycobacterial therapy, and 2 received both. All patients demonstrated significant improvement at the time of follow-up. These findings suggest that disease due to NTM may manifest as diffuse infiltrates in immunocompetent adults and that hot tub use may be an important risk factor for this disease pattern.


Subject(s)
Immunocompromised Host , Mycobacterium avium Complex/isolation & purification , Mycobacterium avium-intracellulare Infection/microbiology , Pneumonia, Bacterial/microbiology , Water Microbiology , Adult , Aged , Alveolitis, Extrinsic Allergic/diagnosis , Baths , Diagnosis, Differential , Female , Glucocorticoids/therapeutic use , Granuloma, Respiratory Tract/diagnosis , Humans , Immunocompetence , Male , Middle Aged , Mycobacterium avium Complex/pathogenicity , Mycobacterium avium-intracellulare Infection/drug therapy , Mycobacterium avium-intracellulare Infection/pathology , Pneumonia, Bacterial/drug therapy , Pneumonia, Bacterial/pathology , Sarcoidosis/diagnosis
13.
Eur Respir J ; 15(2): 373-81, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10706507

ABSTRACT

Pneumonitis is a serious and unpredictable side-effect of treatment with methotrexate (MTX) that may become life-threatening. The clinical and histological features of nine cases of MTX pneumonitis are reported and the literature reviewed. The typical clinical symptoms include progressive shortness of breath and cough, often associated with fever. Hypoxaemia and tachypnoea are always present and crackles are frequently audible. Chest radiography reveals a diffuse interstitial or mixed interstitial and alveolar infiltrate, with a predilection for the lower lung fields. Pulmonary function tests show a restrictive pattern with diminished diffusion capacity. Lung biopsy reveals cellular interstitial infiltrates, granulomas or a diffuse alveolar damage pattern accompanied by perivascular inflammation. These clinical and pathological findings are not specific to MTX pneumonitis and can be seen with other drug-induced lung toxicities. It is important that all patients receiving methotrexate be educated concerning this potential adverse reaction and instructed to contact their physicians should significant new pulmonary symptoms develop while undergoing therapy. If methotrexate pneumonitis is suspected, methotrexate should be discontinued, supportive measures instituted and careful examination for different causes of respiratory distress conducted.


Subject(s)
Antirheumatic Agents/adverse effects , Lung Diseases, Interstitial/chemically induced , Methotrexate/adverse effects , Pneumonia/chemically induced , Aged , Antirheumatic Agents/therapeutic use , Female , Folic Acid Antagonists/adverse effects , Humans , Lung/pathology , Male , Methotrexate/therapeutic use , Middle Aged
14.
JAMA ; 279(6): 455-7, 1998 Feb 11.
Article in English | MEDLINE | ID: mdl-9466639

ABSTRACT

CONTEXT: Zafirlukast is a potent leukotriene antagonist that recently was approved for the treatment of asthma. As use of this drug increases, adverse events that occur at low frequency or in populations not studied in premarketing clinical trials may become evident. OBJECTIVE: To describe a clinical syndrome associated with zafirlukast therapy. DESIGN: Case series. PATIENTS: Eight adults (7 women and 1 man) with steroid-dependent asthma who received zafirlukast. MAIN OUTCOME MEASURES: Development of a clinical syndrome characterized by pulmonary infiltrates, cardiomyopathy, and eosinophilia following the withdrawal of corticosteroid treatment. RESULTS: The clinical syndrome developed while patients were receiving zafirlukast from 3 days to 4 months and from 3 days to 3 months after corticosteroid withdrawal. All 8 patients developed leukocytosis (range, 14.5-27.6 x 10(9)/L) with eosinophilia (range, 0.19-0.71). Six patients had fever (temperature >38.5 degrees C), 7 had muscle pain, 6 had sinusitis, and 6 had biopsy evidence of eosinophilic tissue infiltration. The clinical syndrome improved with discontinuation of zafirlukast treatment and reinitiation of corticosteroid treatment or addition of cyclophosphamide treatment. COMMENT: Development of pulmonary infiltrates, cardiomyopathy, and eosinophilia may have occurred independent of zafirlukast use or may have resulted from an allergic response to this medication. We suspect that these patients may have had a primary eosinophilic infiltrative disorder that had been clinically recognized as asthma, was quelled by steroid treatment, and was unmasked following corticosteroid withdrawal facilitated by zafirlukast.


Subject(s)
Anti-Asthmatic Agents/therapeutic use , Asthma/complications , Asthma/drug therapy , Cardiomyopathies/complications , Eosinophilia/complications , Leukotriene Antagonists , Lung Diseases, Interstitial/complications , Tosyl Compounds/therapeutic use , Adult , Anti-Asthmatic Agents/adverse effects , Anti-Inflammatory Agents/therapeutic use , Asthma/diagnosis , Cardiomyopathies/chemically induced , Cardiomyopathies/diagnosis , Churg-Strauss Syndrome/diagnosis , Diagnosis, Differential , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/etiology , Eosinophilia/chemically induced , Eosinophilia/diagnosis , Female , Glucocorticoids/therapeutic use , Humans , Indoles , Lung Diseases, Interstitial/chemically induced , Lung Diseases, Interstitial/diagnosis , Male , Middle Aged , Phenylcarbamates , Steroids , Sulfonamides , Tosyl Compounds/adverse effects
15.
Clin Chest Med ; 16(3): 393-9, 1995 Sep.
Article in English | MEDLINE | ID: mdl-8521695

ABSTRACT

Rigid bronchoscopy is superior to flexible fiberoptic bronchoscopy in several clinical situations. General anesthesia is usually used with side port ventilation. In children, removal of foreign bodies is an important indication. Tracheal stricture dilatation and cryotherapy are indications in adults, but laser bronchoscopy has become the major indication for rigid bronchoscopy in adult medicine.


Subject(s)
Bronchoscopy , Adult , Bronchoscopes , Bronchoscopy/history , Bronchoscopy/methods , Child , Cryotherapy/methods , Europe , Foreign Bodies/therapy , History, 19th Century , History, 20th Century , Humans , Infant , Infant, Newborn , Laser Therapy/methods , Otolaryngology/history , Tracheal Stenosis/therapy , United States
16.
Chest ; 108(3): 880-3, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7656652

ABSTRACT

Bronchogenic cysts (BCs) are uncommon congenital anomalies. Due to the inherent complications, the mere presence of a BC should warrant surgical therapy. Partial excision of these structures leads to recurrence. Complete surgical excision using a thoracotomy or video-assisted thoracic surgery is the goal. We report a case of recurrent bronchogenic pseudocyst 24 years after initial excision. This case supports the argument for complete surgical excision of BCs at the time of diagnosis.


Subject(s)
Bronchogenic Cyst/diagnostic imaging , Bronchogenic Cyst/surgery , Aged , Humans , Male , Recurrence , Time Factors , Tomography, X-Ray Computed
17.
Am J Respir Crit Care Med ; 149(4 Pt 1): 893-8, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8143052

ABSTRACT

The clinical characteristics and pathology of sarcoidosis are well defined; however, the optimal therapy for this disorder remains unclear. Although patients respond, acutely, to corticosteroid therapy, it is not clear that these agents ultimately alter the natural history of this disease. These observations and that corticosteroids have significant side effects suggest that only patients who will clearly benefit from corticosteroid therapy should be treated. In a prospective study of patients' with sarcoidosis (n = 98), we limited our use of corticosteroids to those patients who had objective evidence of recent deterioration in lung function or serious extrapulmonary disease. All patients with sarcoidosis fulfilling these criteria were treated with corticosteroids. Patients were tapered off corticosteroids after they were treated for 1 yr. Of the 98 study subjects, 91 had not received therapy for the disease and 7 were on therapy before entry into the study. Of the 91 previously untreated patients, 55 were observed without therapy and 36 were treated with corticosteroids. Of those who were observed off therapy, only eight deteriorated. Of these latter patients, six responded and stabilized with the administration of corticosteroids for treatment of the underlying disease, to antibiotics for an associated bronchiectasis, or to diuretics for treatment for congestive heart failure; two were lost to follow-up. None of these six patients deteriorated while receiving corticosteroids. Of the 36 patients who deteriorated and were treated with corticosteroids, 20 remained stable and 16 improved clinically. Of the 37 patients who were eventually tapered off corticosteroids, five deteriorated and required reinitiation of corticosteroid therapy.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Sarcoidosis, Pulmonary/drug therapy , Adult , Clinical Protocols , Female , Humans , Male , Middle Aged , Prednisone/administration & dosage , Prednisone/adverse effects , Prospective Studies , Remission Induction , Sarcoidosis, Pulmonary/diagnosis , Sarcoidosis, Pulmonary/epidemiology , Sarcoidosis, Pulmonary/physiopathology , Statistics as Topic , Time Factors , Treatment Outcome
18.
Am J Respir Crit Care Med ; 149(2 Pt 1): 444-9, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8306043

ABSTRACT

Idiopathic pulmonary fibrosis (IPF) is a progressive form of lung disease with a median survival of less than 5 yr. To address the progressive nature of this disease process, we investigated the determinants of decrements in lung function in patients with IPF. We prospectively evaluated 39 subjects with IPF. Our study subjects were followed for an average of 2 yr (range, 49 to 1,883 days) and lung function was measured on at least two separate occasions (mean = 9.1 separate tests) during the follow-up period. Since IPF is characterized by reduced lung volume and abnormal gas exchange, our analysis focused on the determinants of total lung capacity (TLC) and diffusing capacity of carbon monoxide (DLCO) during the period of observation. Although, on average, there was a 5.3% increase in the TLC and a 9.8% increase in DLCO between the first and last measure of lung function, 25% of the study population experienced a decline in the TLC and 28% of the study population experienced a decline in the DLCO. Decrements in TLC were independently associated with severe dyspnea (p = 0.01) and treatment with cyclophosphamide (p = 0.03). Decrements in DLCO were significantly and independently associated with more pack-years of cigarette smoking (p = 0.02), moderate (p = 0.03) or severe (p = 0.02) dyspnea, and treatment with cyclophosphamide (p = 0.0002). These findings indicate that several clinical characteristics are independently associated with subsequent declines in TLC and DLCO in patients with IPF.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Pulmonary Fibrosis/epidemiology , Bronchoalveolar Lavage Fluid/cytology , Cyclophosphamide/therapeutic use , Female , Follow-Up Studies , Humans , Male , Middle Aged , Multivariate Analysis , Prospective Studies , Pulmonary Diffusing Capacity/physiology , Pulmonary Fibrosis/diagnosis , Pulmonary Fibrosis/drug therapy , Risk Factors , Smoking/epidemiology , Spirometry , Time Factors , Total Lung Capacity/physiology
19.
Am J Respir Crit Care Med ; 149(2 Pt 1): 450-4, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8306044

ABSTRACT

To identify the determinants of survival in patients with idiopathic pulmonary fibrosis (IPF), we performed a survival analysis on 74 subjects with IPF. The study subjects were on average 64 yr of age (range, 25 to 83 yr), 62% were male, and 29% were never smokers. A tissue diagnosis was made in 67 (91%) of our study subjects. These subjects were followed for a mean period of 4 yr (range, 1.4 to 118.8 months) after the onset of pulmonary symptoms. During the period of observation, 41 subjects died (median survival = 28.2 months) and 33 continue to survive (median follow-up period = 60.9 months). A univariate analysis demonstrated that diminished survival was significantly associated with male gender (hazard ratio = 1.98; 95% confidence interval [CI] = 1.01-3.85), a higher FEV1/FVC ratio (hazard ratio = 1.82 [per 10% increase in the FEV1/FVC ratio]; 95% CI = 1.21-2.73), a lower percent predicted FVC (hazard ratio = 0.74; 95% CI = 0.60-0.91), a lower percent predicted total lung capacity (TLC) (hazard ratio = 0.75; 95% CI = 0.60-0.94), a lower percent predicted diffusing capacity of carbon monoxide (DLCO) (hazard ratio = 0.69; 95% CI = 0.53-0.89), a higher ILO profusion category on chest radiograph (hazard ratio = 3.52; 95% CI = 1.58-7.87), and an enhanced release of prostaglandin E2 (PGE2) by cultured alveolar macrophages (hazard ratio = 1.32 [per 10 pm/ml of PGE2]; 95% CI = 1.07-1.62).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Bronchoalveolar Lavage Fluid/cytology , Pulmonary Fibrosis/mortality , Female , Follow-Up Studies , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Pulmonary Fibrosis/diagnosis , Regression Analysis , Sex Factors , Smoking/epidemiology , Spirometry , Survival Analysis , Time Factors
20.
Chest ; 103(1): 69-73, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8417939

ABSTRACT

To evaluate the outcome of subjects with idiopathic pulmonary fibrosis (IPF) whose conditions clinically deteriorate while receiving corticosteroid therapy, we studied 12 of these subjects (7 male, 5 female) who received subsequent therapy with intravenous (IV) pulse cyclophosphamide (CPX). Seven of the 12 study subjects died during the course of therapy. Six of these subjects died of respiratory failure, and one died of cholecystitis. Among those who died, the mean age at diagnosis was 63 years compared with 57 years in those who have continued to survive (p = 0.29). Smoking status and pack-years of cigarette smoking were similar between those subjects who died and those who continue to survive. However, subjects who died received CPX for a mean of 6 months, while subjects still living have received CPX for a mean of 16 months (p = 0.01). Subjects who died were given a CPX a mean of 64 months after the onset of symptoms, compared with a mean of 50 months for subjects who are still alive (p = 0.57). Interestingly, there were no significant differences in measures of pulmonary function between living and dead subjects. In fact, measures of lung function and gas exchange remained stable in both groups throughout the period of observation. These data suggest that (1) measures of lung function may not be a reliable indicator of patient mortality in end-stage IPF, and (2) while not statistically significant, these data raise the possibility that duration of symptomatic disease may play a role in the outcome of IPF patients receiving alternative therapeutic agents after failure of corticosteroid therapy. In future intervention trails, controlling entry criteria for duration of disease may prove helpful in determining the effects of these agents on the disease process. These data do not permit a determination of the effect of CPX in patients with IPF.


Subject(s)
Cyclophosphamide/therapeutic use , Prednisone/therapeutic use , Pulmonary Fibrosis/drug therapy , Administration, Oral , Age Factors , Cyclophosphamide/administration & dosage , Drug Therapy, Combination , Dyspnea/classification , Dyspnea/physiopathology , Female , Follow-Up Studies , Forced Expiratory Volume/physiology , Humans , Injections, Intravenous , Male , Middle Aged , Prednisone/administration & dosage , Prospective Studies , Pulmonary Diffusing Capacity/physiology , Pulmonary Fibrosis/classification , Pulmonary Fibrosis/physiopathology , Survival Rate , Time Factors , Total Lung Capacity/physiology , Treatment Outcome , Vital Capacity/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...